| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 36 |
| 1 | FUROSEMIDE | 33 |
| 2 | SPIRONOLACTONE | 30 |
| 3 | ABIRATERONE ACETATE | 25 |
| 4 | POTASSIUM CHLORIDE | 25 |
| 5 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 25 |
| 6 | POTASSIUM CHLORIDE ORAL | 25 |
| 7 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 25 |
| 8 | METOPROLOL TARTRATE | 19 |
| 9 | METOPROLOL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 1 | 0.0054 |
| 1 | BAXDROSTAT | 1 | 0.0037 |
| 2 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 3 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 4 | CYCLOSERINE | 3 | 0.0013 |
| 5 | DOXYCYCLINE MONOHYDRATE | 2 | 0.0013 |
| 6 | HISTRELIN ACETATE | 1 | 0.0011 |
| 7 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 8 | EPLERENONE | 12 | 0.0009 |
| 9 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Dihydropyridine Calcium Channel Blocker [EPC] | 54 |
| 1 | Aldosterone Antagonist [EPC] | 38 |
| 2 | Corticosteroid [EPC] | 37 |
| 3 | Calcium Channel Blocker [EPC] | 36 |
| 4 | Loop Diuretic [EPC] | 35 |
| 5 | beta-Adrenergic Blocker [EPC] | 31 |
| 6 | Osmotic Laxative [EPC] | 30 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 27 |
| 8 | Potassium Salt [EPC] | 25 |
| 9 | Atypical Antipsychotic [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Phosphate Binder [EPC] | 2 | 0.0007 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 4 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 6 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 8 | Recombinant Human Growth Hormone [EPC] | 6 | 0.0003 |
| 9 | Aldosterone Antagonist [EPC] | 38 | 0.0002 |